Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Advanced”

1,061 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,061 results

Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Large-scale testing (Phase 3)Ended earlyNCT00543205
What this trial is testing

Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment

Who this might be right for
Advanced Melanoma and Normal or ImpairedHepatic Function
Genta Incorporated 6
Very early researchLooking for participantsNCT04741997
What this trial is testing

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVBRAF V600 Mutation
H. Lee Moffitt Cancer Center and Research Institute 50
Early research (Phase 1)Study completedNCT00496860
What this trial is testing

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

Who this might be right for
Progressive Metastatic Malignancies
Altor BioScience 26
Large-scale testing (Phase 3)Study completedNCT01359956
What this trial is testing

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

Who this might be right for
Malignant MelanomaRecurrent Melanoma
National Cancer Institute, Naples 269
Not applicableStudy completedNCT02310451
What this trial is testing

Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes

Who this might be right for
Metastatic Melanoma
Centre Hospitalier Universitaire de Nice 15
Very early researchStudy completedNCT05279027
What this trial is testing

Zr89 + PET Companion Trial

Who this might be right for
Melanoma (Skin)
Abramson Cancer Center at Penn Medicine 6
Large-scale testing (Phase 3)Active Not RecruitingNCT04674683
What this trial is testing

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

Who this might be right for
Unresectable or Metastatic MelanomaProgressive Brain Metastasis
HUYABIO International, LLC. 450
Early research (Phase 1)Study completedNCT02680184
What this trial is testing

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 199
Testing effectiveness (Phase 2)Study completedNCT00003362
What this trial is testing

Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT03448666
What this trial is testing

ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases

Who this might be right for
Malignant Melanoma
European Institute of Oncology
Early research (Phase 1)Study completedNCT00324623
What this trial is testing

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Prof. Serge Leyvraz 8
Testing effectiveness (Phase 2)Ended earlyNCT04799054
What this trial is testing

TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+4 more
Ascendis Pharma Oncology Division A/S 188
Early research (Phase 1)WithdrawnNCT02210104
What this trial is testing

Adoptive Therapy Using Antigen-Specific CD4 T-Cells

Who this might be right for
MelanomaSarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03724968
What this trial is testing

Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression

Who this might be right for
Metastatic MelanomaAdvanced MelanomaMetastatic Melanoma Stratified by MHC-II Expression
Elizabeth Davis 2
Testing effectiveness (Phase 2)WithdrawnNCT02736123
What this trial is testing

Neoadjuvant Combination Biotherapy With Ipilimumab and Nivolumab or Nivolumab Alone

Who this might be right for
Melanoma
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00602576
What this trial is testing

Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Melanoma (Skin)
Abramson Cancer Center at Penn Medicine 169
Not applicableStudy completedNCT02990611
What this trial is testing

Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,087
Testing effectiveness (Phase 2)Looking for participantsNCT06249048
What this trial is testing

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Who this might be right for
Advanced Solid Tumor
Strand Therapeutics Inc. 108
Load More Results